1. Home
  2. ONL vs RNAC Comparison

ONL vs RNAC Comparison

Compare ONL & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion Office REIT Inc.

ONL

Orion Office REIT Inc.

HOLD

Current Price

$2.89

Market Cap

141.5M

Sector

Real Estate

ML Signal

HOLD

Logo Cartesian Therapeutics Inc.

RNAC

Cartesian Therapeutics Inc.

HOLD

Current Price

$8.54

Market Cap

168.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONL
RNAC
Founded
2021
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
141.5M
168.3M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
ONL
RNAC
Price
$2.89
$8.54
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$3.00
$34.00
AVG Volume (30 Days)
317.2K
183.7K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
2.83%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$147,647,000.00
$2,797,000.00
Revenue This Year
$4.10
N/A
Revenue Next Year
$3.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.63
$5.60
52 Week High
$3.01
$14.56

Technical Indicators

Market Signals
Indicator
ONL
RNAC
Relative Strength Index (RSI) 67.00 69.06
Support Level $2.43 $5.89
Resistance Level N/A $9.25
Average True Range (ATR) 0.13 0.53
MACD 0.02 0.22
Stochastic Oscillator 87.16 96.53

Price Performance

Historical Comparison
ONL
RNAC

About ONL Orion Office REIT Inc.

Orion Properties Inc is an internally managed real estate investment trust engaged in the ownership, acquisition, and management of a diversified portfolio of office properties located in high-quality suburban markets across the United States and leased mainly on a single-tenant net lease basis to creditworthy tenants. Its portfolio is comprised of traditional office properties, as well as governmental, medical office, flex/laboratory, and R&D and flex/industrial properties. The company is focused on shifting its portfolio concentration over time away from traditional office properties, towards more dedicated use assets with specialized uses that include an office component. It operates in one business segment: commercial real estate.

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Share on Social Networks: